CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing number of surgeries
4.1.2. Government policies for preventing healthcare-associated infections
4.1.3. Increasing healthcare expenditure
4.1.4. Increasing incidence of healthcare-associated infections
4.2. Market Restraints & Challenges
4.2.1. The high cost of software
4.2.2. Under developed IT infrastructure in developing countries
4.3. Market Opportunities
4.3.1. High growth in developing counties across APAC and Latin America
4.3.2. Cloud-Based software offers significant growth opportunities
CHAPTER 5 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET – BY PRODUCT
5.1. Introduction
5.2. Software
5.2.1. On-Premise Software
5.2.2. Web-Based Software
5.3. Services
5.3.1. Product Support & Maintenance Services
5.3.2. Training & Consulting Services
5.3.3. Implementation Services
CHAPTER 6 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET – BY END USER
6.1. Introduction
6.2. Hospitals
6.2.1. Large hospitals
6.2.2. Medium-sized hospitals
6.2.3. Small hospitals
6.3. Long-term care facilities
6.3.1. Nursing homes
6.3.2. Skilled nursing facilities
6.3.3. Assisted living facilities
6.4. Other End Users
CHAPTER 7 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET - BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.7. Switzerland
7.4.8. Poland
7.4.9. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET - COMPANY PROFILES
8.1. Becton, Dickinson and Company.
8.2. Premier Inc.
8.3. DEB Group Ltd.
8.4. RL Solutions.
8.5. Hygreen Inc.
8.6. Baxter International Inc.
8.7. Atlas Medical Software.
8.8. Gojo Industries Inc.
8.9. ICNet International Limited.
8.10. Wolters Kluwer N.V.
8.11. Truven Health Analytics.
8.12. Cerner Corporation.
8.13. Iatric systems, Inc.
8.14. Pera health Inc.
8.15. BioMerieux
CHAPTER 9 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET – COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10 MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11 APPENDIX
11.1. List of Tables
11.2. List of Figures
